Investing

First Look Analysts Research Calls for Friday, February 24

Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Century Aluminum (CENX) upgraded to Peer Perform from Underperform at Wolfe Research

> Esperion Therapeutics (ESPR) upgraded to Buy from Hold at Jefferies; tgt $12

> Grainger (GWW) upgraded to Sector Perform from Underperform at RBC Capital Mkts; tgt raised to $679

> LyondellBasell (LYB) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $130

> NeoGenomics (NEO) upgraded to Buy from Hold at The Benchmark Company; tgt $20

> Youdao (DAO) upgraded to Buy from Hold at Jefferies; tgt raised to $10

Downgrades:

> C4 Therapeutics (CCCC) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $5

> CURO Group (CURO) downgraded to Underperform from Neutral at Credit Suisse; tgt lowered to $4

> Moderna (MRNA) downgraded to Underperform from Market Perform at SVB Securities; tgt lowered to $93

> Nektar Therapeutics (NKTR) downgraded to Underperform from Hold at Jefferies; tgt lowered to $1.50

> New York Mortgage Trust (NYMT) downgraded to Neutral from Buy at Ladenburg Thalmann

> OGE Energy (OGE) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $39

Others:

> Biomea Fusion (BMEA) initiated with a Buy at Citigroup; tgt $20

> Erasca (ERAS) initiated with a Buy at Goldman; tgt $10

> KE Holdings (BEKE) initiated with a Buy at Daiwa Securities

Want to Retire Early? Start Here (Sponsor)

Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

 

Have questions about retirement or personal finance? Email us at [email protected]!

By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.

By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.